Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Alterations in brain metabolism during the first year of HIV infection.

Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Halpern EF, Rosenberg ES, Williams K, González RG.

J Neurovirol. 2011 Jun;17(3):220-9. doi: 10.1007/s13365-011-0030-9. Epub 2011 Apr 15.

2.

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA; HIV Neuroimaging Consortium.

J Neurovirol. 2014 Jun;20(3):294-303. doi: 10.1007/s13365-014-0246-6. Epub 2014 Apr 3.

3.

Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.

Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2010 Nov;16(6):435-44. doi: 10.3109/13550284.2010.520817. Epub 2010 Oct 20.

4.

Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.

Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I; HNRC Group.

J Neurovirol. 2007 Apr;13(2):150-9.

PMID:
17505983
5.

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA; HIV MRS Consortium.

Neuroimage. 2004 Dec;23(4):1336-47.

PMID:
15589098
6.

Effect of aging on brain metabolism in antiretroviral-naive HIV patients.

Ernst T, Chang L.

AIDS. 2004 Jan 1;18 Suppl 1:S61-7.

PMID:
15075499
7.

A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.

Fuller RA, Westmoreland SV, Ratai E, Greco JB, Kim JP, Lentz MR, He J, Sehgal PK, Masliah E, Halpern E, Lackner AA, González RG.

BMC Neurosci. 2004 Mar 5;5:10.

8.

Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.

Chang L, Ernst T, Speck O, Grob CS.

Am J Psychiatry. 2005 Feb;162(2):361-9.

9.

Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.

Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF, Venna N, Williams K, Rosenberg ES, González RG.

Neurology. 2009 Apr 28;72(17):1465-72. doi: 10.1212/WNL.0b013e3181a2e90a.

10.

Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.

Byrnes V, Miller A, Lowry D, Hill E, Weinstein C, Alsop D, Lenkinski R, Afdhal NH.

J Hepatol. 2012 Mar;56(3):549-56. doi: 10.1016/j.jhep.2011.09.015. Epub 2011 Oct 23.

PMID:
22027578
11.

Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.

Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E.

Neuroimage. 2002 Nov;17(3):1638-48.

PMID:
12414302
12.

Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.

Coley JS, Calderon TM, Gaskill PJ, Eugenin EA, Berman JW.

PLoS One. 2015 Feb 3;10(2):e0117450. doi: 10.1371/journal.pone.0117450. eCollection 2015.

13.

Brain biochemical correlates of the plasma homocysteine level: a proton magnetic resonance spectroscopy study in the elderly subjects.

Chen CS, Kuo YT, Tsai HY, Li CW, Lee CC, Yen CF, Lin HF, Ko CH, Juo SH, Yeh YC, Liu GC.

Am J Geriatr Psychiatry. 2011 Jul;19(7):618-26. doi: 10.1097/JGP.0b013e318209ddf1.

PMID:
21709607
14.

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex.

Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E.

Neurology. 1999 Jan 1;52(1):100-8.

PMID:
9921855
15.

Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2013 Jun;19(3):209-18. doi: 10.1007/s13365-013-0162-1. Epub 2013 Apr 24.

16.

CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.

Fischer-Smith T, Tedaldi EM, Rappaport J.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):417-21. doi: 10.1089/aid.2007.0193.

17.

Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.

Keller MA, Venkatraman TN, Thomas A, Deveikis A, LoPresti C, Hayes J, Berman N, Walot I, Padilla S, Johnston-Jones J, Ernst T, Chang L.

Neurology. 2004 May 25;62(10):1810-7.

PMID:
15159483
18.

Proton magnetic resonance spectroscopy of late-life major depressive disorder.

Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.

Psychiatry Res. 2009 Jun 30;172(3):210-4. doi: 10.1016/j.pscychresns.2009.01.003. Epub 2009 Mar 20.

PMID:
19303260
19.

Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage.

Kim WK, Sun Y, Do H, Autissier P, Halpern EF, Piatak M Jr, Lifson JD, Burdo TH, McGrath MS, Williams K.

J Leukoc Biol. 2010 Apr;87(4):557-67. doi: 10.1189/jlb.0209082. Epub 2009 Oct 20.

20.

Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?

Castley A, Berry C, French M, Fernandez S, Krueger R, Nolan D.

PLoS One. 2014 Dec 29;9(12):e115226. doi: 10.1371/journal.pone.0115226. eCollection 2014.

Supplemental Content

Support Center